Macrophages lacking TSC2 have mTORC1-dependent increased GPNMB and ameliorate ventricular dysfunction/remodeling after ischemia-reperfusion
Year: 2025
Type: article
Abstract: Macrophages (MΦ) modulate myocardial inflammation and repair after ischemia-reperfusion (I/R) injury. The mechanistic target of rapamycin (mTOR) regulates MΦ phenotype and functionality, but studies conflict regarding its pro- or anti-inflammatory role. To test this, myeloid TSC2 depleted (MΦ TSC2−/− ) mice were generated by crossing Lys2 Cre with TSC2 flx/flx . In vitro, bone marrow-derived MΦ TSC2−/− vs. control MΦ had greater mTORC1 and less mTORC2 activity coupled with differential responses to pro- or anti-inflammatory ligands. These disparities were eliminated by inhibiting mTORC1 with rapamycin. MΦ TSC2−/− mice had substantially less cardiac dysfunction and ventricular remodeling after I/R, with reduced lung edema and activation of stress/pro fibrotic genes. These differences were eliminated by treating mice with rapamycin, supporting mTORC1 dependence. Post I/R MΦ TSC2−/− myocardium had fewer pro-inflammatory (CCR2 + MHC-II hi ) MΦ, LY6C + monocytes, LY6G + neutrophils, and CD8 + T cells at 5-days post-I/R, and fewer CCR2 + but more CCR2 − MΦ 2-wks after I/R. Synthesis of glycoprotein nonmetastatic melanoma protein B (GPNMB), a MΦ secreted anti-inflammatory protein was greater in MΦ TSC2−/− macrophages and myocardium after I/R in an mTORC1 dependent manner. Thus, constitutive mTORC1 activation in MΦ depresses pro-inflammatory cell infiltration, increases GPNMB protein expression, and preserves heart function following I/R. This reveals beneficial effects of a MΦ-dependent mTORC1-GPNMB cascade on the post I/R heart.
Source: Scientific Reports
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
Awards: G1025611983, G2551199298, Intersection of Obesity and Heart Failure with Preserved Ejection Fraction, Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis, G7297477326, G8366525084, G8928621865, Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis, Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells, Myocardial-associated B lymphocytes and inflammatory injury, Pathophysiology of Myocardial Disease
OpenAlex ID: W4416389688
